Mediwelcome Healthcare Management & Technology Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Mediwelcome Healthcare Management & Technology.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 19.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Improved Revenues Required Before Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Shares Find Their Feet
Mar 06
There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues
Aug 15Mediwelcome Healthcare Management & Technology (HKG:2159) Might Be Having Difficulty Using Its Capital Effectively
Aug 12Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)
Apr 08Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital
Jan 24In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Mediwelcome Healthcare Management & Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 331 | -94 | N/A | N/A | N/A |
| 9/30/2023 | 315 | -86 | N/A | N/A | N/A |
| 6/30/2023 | 298 | -79 | -22 | -18 | N/A |
| 3/31/2023 | 311 | -84 | -22 | -18 | N/A |
| 12/31/2022 | 323 | -89 | -23 | -18 | N/A |
| 9/30/2022 | 432 | -57 | -18 | -14 | N/A |
| 6/30/2022 | 541 | -26 | -13 | -10 | N/A |
| 3/31/2022 | 625 | -11 | -19 | -5 | N/A |
| 12/31/2021 | 708 | 5 | -25 | 0 | N/A |
| 9/30/2021 | 671 | 6 | -12 | 15 | N/A |
| 6/30/2021 | 633 | 8 | 2 | 30 | N/A |
| 3/31/2021 | 533 | 14 | 10 | 31 | N/A |
| 12/31/2020 | 432 | 21 | 17 | 31 | N/A |
| 9/30/2020 | 418 | 19 | 21 | 38 | N/A |
| 6/30/2020 | 404 | 16 | 25 | 46 | N/A |
| 3/31/2020 | 416 | 18 | 8 | 25 | N/A |
| 12/31/2019 | 427 | 21 | -8 | 5 | N/A |
| 12/31/2018 | 299 | 38 | 54 | 59 | N/A |
| 12/31/2017 | 259 | 30 | -5 | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2159's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if 2159's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 2159's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 2159's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 2159's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2159's Return on Equity is forecast to be high in 3 years time